As of 2023, Gavin MacBeath holds stock options for 1,121,300 shares of TScan Therapeutics. His stock holdings have seen fluctuations since he joined TScan, with options value being significant, estimated around $2.49 per share at the time of his stock...

As of 2023, Gavin MacBeath holds stock options for 1,121,300 shares of TScan Therapeutics. His stock holdings have seen fluctuations since he joined TScan, with options value being significant, estimated around $2.49 per share at the time of his stock option grant. This indicates a strong vested interest in the company's future success, as his wealth in TScan's stock is contingent upon the company's performance and growth. Specifically, Dr. MacBeath has seen considerable value in his options, as reflected in his prior roles in the biotech sector. His engagement in stock options helps align his interests with those of the shareholders, emphasizing a commitment to driving the company forward.